Allison Duettmann
@allisondman
CEO @foresightinst, co-author https://t.co/QSt9NXmDOl…, founder https://t.co/hXNI6dbDRD, co-initiator @longevityprize, advisor @agingbiomarkers
ID:799379530993385472
http://www.foresight.org 17-11-2016 22:31:46
1,4K Tweets
4,8K Followers
1,3K Following
If you're working at the intersection of cryptography, security, and AI, this is the last chance to apply to Foresight Institute May 14-15, AGI: Cryptography, Security & Multipolar Scenarios Workshop. We'll explore AI infosec, privacy in AI evaluation, multi-agent alignment,…
.Scott Alexander was nice enough to critique my position on medicine, & then to respond to my response. Here I respond to that. overcomingbias.com/p/second-respo…
Announcing the 2024 The Roots of Progress Blog-Building Intensive, the second cohort of our 8-week program for aspiring progress writers to start or grow a blog.
Learn about progress studies, get into a regular writing habit, improve your writing, and build your audience
Can’t wait to chat with the wonderful Marta Belcher on AI, Decentralization, and Regulating Emerging Technologies — thanks for making this event possible Filecoin Foundation!
ICYMI, Day 1️⃣ of Paths to Progress (co-hosted with Foresight Institute) highlighted Longevity Biotechnology with presentations by:
🎤 Aaron King
🎤 Allison Duettmann
🎤 Amit Deshwar
🎤 & more
#LabWeekPG 🌿
⏪ Watch a highlight from the session on genetic medicine pathways. 👇
Great primer on hi-fi vs. lo-fi approaches to WBE by Patrick Mineault: neuroai.science/p/connectomics…
Very excited to settle in Edge City in California in June, and to curate LabWeek on Breakthrough Tech w/ Foresight Institute and Protocol Labs.
this paper on collective intelligence by Michael Levin is one of the most mind-blowing things I've read in a while
it's full of examples of the under-appreciated intelligence of biological systems, with some deep perspective shifts on our understanding of ourselves
thread:
Today we unveil the Pareto Holdings pH Fellowship with the goal of accelerating efforts to take on aging and age-related diseases.
We have so far backed nearly 1,000 early stage startups around the world, mostly focused on being the first to take a chance on great teams.
We…